Y mAbs Therapeutics Net Asset Quality Index
Y mAbs Therapeutics net asset quality index. Y mAbs Therapeutics (YMAB) has a Net Asset Quality Index of 74.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $117.21 Million minus total liabilities of $29.72 Million yields net assets of $87.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Y mAbs Therapeutics net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Y mAbs Therapeutics (2016–2024)
Net asset quality index of Y mAbs Therapeutics from 2016 to 2024. This chart shows how Y mAbs Therapeutics's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 74.6%, representing net assets of $87.49 Million against total assets of $117.21 Million USD. Check Y mAbs Therapeutics (YMAB) strategic asset index to assess the company's strategic physical and investment asset allocation.
Y mAbs Therapeutics Net Asset Quality Index by Year (2016–2024)
Y mAbs Therapeutics net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Y mAbs Therapeutics from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Y mAbs Therapeutics (YMAB) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 76.7% | $92.00 Million | $119.90 Million | $27.90 Million | ▼ -2.2 pp |
| 2023 | 79.0% | $100.98 Million | $127.87 Million | $26.88 Million | ▲ +1.8 pp |
| 2022 | 77.2% | $109.22 Million | $141.46 Million | $32.23 Million | ▼ -7.4 pp |
| 2021 | 84.6% | $180.11 Million | $212.78 Million | $32.68 Million | ▲ +4.5 pp |
| 2020 | 80.2% | $105.84 Million | $132.05 Million | $26.21 Million | ▼ -11.8 pp |
| 2019 | 91.9% | $198.90 Million | $216.37 Million | $17.46 Million | ▼ -0.6 pp |
| 2018 | 92.5% | $140.53 Million | $151.92 Million | $11.40 Million | ▲ +3.3 pp |
| 2017 | 89.2% | $82.15 Million | $92.13 Million | $9.97 Million | ▲ +19.3 pp |
| 2016 | 69.9% | $12.06 Million | $17.26 Million | $5.20 Million | — |